Document MJ48ELza9qkM5b6z6KxQKVvgM

To: From: Cc: Bcc: Received Date: Subject: 'Howard Feldman' <Feldman@api.org> Snyder, Phil J SCC-DCS/2 <lO=SHELLlOU=MSXSCC/CN=RECIPIENTS/CN=PS193987> 2007-03-06 22:44:53 GMT comments Phil Snyder Global Manager Downstream Product Stewardship Shell Chem ical LP One Shell Plaza, P.O. Box 2463, Houston, TX 77252-2463 Tel: +1 713241 7826 Fax: +1 713 - 241 2494 Other Tel: +1 832-721-6493 Email: Phil.Snyder@Shell.com Internet: http://www.shell.com/chemicals Attachments: Shanghai extension 3-6-07.ZIP SHELL-MCCLURG-06S147 March 5,2007 Via Electronic and U.S. Mail Richard Irons, PhD, DABT Principal Investigator, Shanghai Health Study University of Colorado Health Sciences Center 4200 East 9th Avenue, C238 Denver, CO 80262 Ralph J Altiere, PhD Dean, School of Pharmacy University of Colorado Health Sciences Center 4200 East 9th Avenue, C238 Denver, CO 80262 Re: The Shanghai Health Study Dear Drs. Irons and Altiere: We are writing on behalf of the the scientific and clinical research being We appreciate Dr. Shanghai and We (API) in support of '-HH"HE:,uU~ Health Study. unique project in of this worthy effort. of the Benzene Health Research study (contingent upon API lm1[10nal tenns of the study being ~~~'''~~,.u~ Quality Assurance/Quality progress and payment. Please see attached and API have considered Dr Irons draft Budget for Extension and JCML Transition funding up to $6,559,864 has been provisionally for the following (as described in the referenced Plan A Study ~VJ.HLH"''' Total (Tables I and 2) $5,759,864 Plan B Laboratory Transition Personnel Proposed Budget (From Table 3) $400,000 Post Study Costs for continued publication of study findings $400,000 TOTAL $6.559.864 Formal authorization and disbursement of these additional monies are contingent upon successful execution of an agreement between API and the research entity that will be continuing the study. API Exhibits A-I to A-III, Proposal Guide For Prospective SHELL-MCCLURG-065148